Editor's letter

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

Welcome to 2025. The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new guidance, and broader political shifts. This month's cover feature examines the biggest factors to keep an eye on as the year unfolds.

Also in this issue, we explore the World Health Organisation's (WHO) recent trial guidance, which goes beyond ethnic and gender diversity, attempting to account for patients who are pregnant, lactating, or from low-middle income countries. The issue also features an interview on the burden of red tape towards conducting radiopharmaceutical trials.

Following the recent JP Morgan Healthcare Conference, this issue also features analyst commentary which reflects on whether announcements made during the conference indicate a rebound for biopharma M&A activity.

All this and the latest pharma industry news, comment, and analysis from GlobalData.

Ross Law, deputy editor